Genitope Corp (GTOP.PK)

GTOP.PK on OTC Markets Group

0.00USD
24 Jul 2014
Price Change (% chg)

$0.00 (+4.00%)
Prev Close
$0.00
Open
$0.00
Day's High
$0.00
Day's Low
$0.00
Volume
2,000
Avg. Vol
8,556
52-wk High
$0.01
52-wk Low
$0.00

GTOP.PK

Chart for GTOP.PK

About

Genitope Corporation is a development-stage enterprise focused on the research and development of immunotherapies for the treatment of cancer. Until the recent suspension of the development program, the Company's lead product candidate was MyVax personalized immunotherapy (MyVax), indicated for follicular B-cell non-Hodgkin’s... (more)
No analyst recommendations are available for GTOP.PK.

Overall

Beta: -2.84
Market Cap (Mil.): $0.11
Shares Outstanding (Mil.): 42.98
Dividend: --
Yield (%): --

Financials

  GTOP.PK Industry Sector
P/E (TTM): -- 106.14 36.21
EPS (TTM): -2.46 -- --
ROI: -109.22 -0.01 18.26
ROE: -210.59 -0.85 19.13
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$472.00
Provider: GlobalData
$100.00
Provider: GlobalData
$300.00
Provider: GlobalData
$300.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks